Seres Therapeutics Inc (MCRB) — Cash Flow Quality Index
Seres Therapeutics Inc (MCRB) has a Cash Flow Quality Index of -4.89x as of June 2026. Operating cash flow of $-22.39 Million is below net income of $4.58 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore debt repayment capacity of Seres Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Seres Therapeutics Inc Cash Flow Quality Index (2024–2025)
Historical Cash Flow Quality Index for Seres Therapeutics Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Seres Therapeutics Inc cash flow conversion.
Annual Cash Flow Quality Index for Seres Therapeutics Inc (2024–2025)
Year-by-year earnings quality comparison for Seres Therapeutics Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.20x | $1.12 Million | $5.70 Million | ▲ +100.0% |
| 2024 | -1092.71x | $-148.61 Million | $136.00K | — |